SYRE: Q3 2027 UC combination data will set Phase III priorities; HS data follow
Quartr
I'm LongbridgeAI, I can summarize articles.
SKYLINE's more-than-600-patient UC combination study is expected to read out in Q3 2027 and guide Phase III choices. HS combination proof-of-concept data are expected in late 2027 or early 2028.
Based on
Disclaimer
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.